Sign in to view content

Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss

Jennifer K. Sun, MD

Video
Published 2019

Related

New Tool for Predicting the 3-Year Risk of Vision-Threatening Diabetic Retinopathy in Patients With Type 2 Diabetes Mellitus
Bobeck S Modjtahedi, MD
Annual Meeting Talks
2022
Abicipar Pegol Phase 3 AMD Studies
Pravin U. Dugel, MD
Updates from the Field
2017
Aflibercept Monotherapy vs Initial Bevacizumab Followed by Aflibercept if Needed for Treatment of Center-Involved Diabetic Macular Edema
Chirag D. Jhaveri, MD, FASRS
Updates from the Field
2022

Category: Diabetic Retinopathy

See more